1B6J : HIV-1 PR with PI1+SO4, 1.85A, P 21 21 21 1B6K : HIV-1 PR with PI5+S04, 1.85A, P 21 21 21 1B6L : HIV-1 PR with PI4+SO4, 1.75A, P 21 21 21 1B6M : HIV-1 PR with PI6+SO4, 1.85A, P 21 21 21 1B6P : HIV-1 PR with PI7+SO4, 2.00A, P 21 21 21 1C6X : HIV-1 PR with 3IN, 2.50A, P 21 21 21 1C6Z : HIV-1 PR with ROC, 2.50A, P 21 21 21 1CPI : HIV-1 PR with CYCLIC PEPTIDE, 2.05A, P 21 21 21 1D4K : HIV-1 PR with BEH, 1.81A, P 21 21 21 1D4L : HIV-1 PR with PI9+SO4, 1.75A, P 21 21 21 1DAZ : HIV-1 PR (mutant) with PEPTIDE INHIBITOR, 1.55A, P 21 21 21 1DIF : HIV-1 PR with A85+BME, 1.70A, P 21 21 21 1DW6 : HIV-1 PR (L90M) with ANALOGUE OF CA-P2 PROCESSING SITE, 1.88A, P 21 21 21 1F7A : PR (Q7K D25N) with CA-P2 SUBSTRATE, 2.00A, P 21 21 21 1FEJ : HIV-1 PR with PEPTIDE+ACE, 1.78A, P 21 21 21 1FF0 : HIV-1 PR with PEPTIDE+ACE, 1.85A, P 21 21 21 1FFF : HIV-1 PR with PEPTIDE+NH2, 1.90A, P 21 21 21 1FG8 : HIV-1 PR with PEPTIDE+NH2, 1.85A, P 21 21 21 1FGC : HIV-1 PR with PEPTIDE+ACE, 1.90A, P 21 21 21 1HIH : HIV-1 PR with BME+C20, 2.20A, P 21 21 21 1HIV : HIV-1 PR with PEPTIDE+O, 2.00A, P 21 21 21 1HPX : HIV-1 PR with KNI, 2.00A, P 21 21 21 1HVC : HIV-1 PR (TETHERED) with A79, 1.80A, P 21 21 21 1HVI : HIV-1 PR with A77, 1.80A, P 21 21 21 1HVJ : HIV-1 PR with A78, 2.00A, P 21 21 21 1HVK : HIV-1 PR with A79, 1.80A, P 21 21 21 1HVL : HIV-1 PR with A76, 1.80A, P 21 21 21 1HVS : HIV-1 PR (V82A) with A77, 2.25A, P 21 21 21 1K6C : HIV-1 PR with ACT+MK1, 2.20A, P 21 21 21 1K6P : HIV-1 PR with ACT+XN3, 2.20A, P 21 21 21 1K6T : HIV-1 PR with ACT+XN1, 2.25A, P 21 21 21 1K6V : HIV-1 PR with ACT+XN2, 2.20A, P 21 21 21 1KJ7 : HIV-1 PR (D25N,Q7K) with P2-NC SUBSTRATE, 2.00A, P 21 21 21 1KJF : HIV-1 PR (D25N,Q7K) with p1-p6 SUBSTRATE, 2.00A, P 21 21 21 1KJG : HIV-1 PR (D25N,Q7K) with RT- RH SUBSTRATE, 2.00A, P 21 21 21 1KJH : HIV-1 PR (D25N,Q7K) with RH- IN SUBSTRATE, 2.00A, P 21 21 21 1KZK : HIV PR with CL+EDO+JE2, 1.09A, P 21 21 21 1MT7 : HIV-1 PR (Q7K, D25N, L63P, V82A) with PEPTIDE+ACT, 1.90A, P 21 21 21 1MT8 : HIV-1 PR (Q7K, D25N, L63P, V82A) with PEPTIDE+ACT, 2.15A, P 21 21 21 1MT9 : HIV-1 PR (Q7K, D25N, L63P, V82A) with PEPTIDE+ACT, 2.00A, P 21 21 21 1MTB : HIV-1 PR (mutant) with ASN+DIQ+HPH+NTB+QNC (SAQUINAVIR?), 2.50A, P 21 21 21 1MTR : HIV-1 PR with PEPTIDE+CH2+SO4, 1.75A, P 21 21 21 1NH0 : HIV-1 PR with PEPTIDE+BME+NH2+SO4, 1.03A, P 21 21 21 1NPA : HIV-1 PR with 3NH, 2.00A, P 21 21 21 1ODW : HIV-1 PR with BOC+DMN+HPH, 2.10A, P 21 21 21 1OHR : HIV-1 PR with 1UN (NELFINAVIR), 2.10A, P 21 21 21 1SDU : HIV-1 PR (V82A, L90M) with ACT+MK1+SO4 (indinavir?), 1.25A, P 21 21 21 1T3R : HIV-1 PR with 017+PO4, 1.20A, P 21 21 21 1T7I : HIV-1 PR with 017+ACT+PO4, 1.35A, P 21 21 21 1T7J : HIV-1 PR (L63P/V82T/I84V) with 478+ACT (amprenavir), 2.20A, P 21 21 21 1TSQ : HIV-1 PR (V82A/D25N) with PEPTIDE+ACT, 2.00A, P 21 21 21 1TSU : HIV-1 PR (WT/D25N) with PEPTIDE, 2.10A, P 21 21 21 1XL2 : HIV-1 PR with 189+CL+GOL, 1.50A, P 21 21 21 1Z1H : HIV-1 PR with HBB+SO4, 1.85A, P 21 21 21 1Z1R : HIV-1 PR with HBH+SO4, 1.85A, P 21 21 21 1Z8C : HIV-1 PR (l63P, A71V, V82T, I84V) with peptide+NH2+SO4, 2.20A, P 21 21 21 2AID : HIV-1 PR with CL+THK, 1.90A, P 21 21 21 2AVO : HIV-1 PR (L24I, I50V, G73S) with ACY+DMS+GOL+MK1+SO4, 1.10A, P 21 21 21 2AVS : HIV-1 PR (L24I, I50V, G73S) with ACY+DMS+MK1+PO4+SO4, 1.10A, P 21 21 21 2F3K : HIV-1 PR with PO4+RO1, 1.60A, P 21 21 21 2FGU : HIV-1 PR (T80S) with ASN+DIQ+HPH+NTB+PO4+QNC (saquinavir), 2.00A, P 21 21 21 2FGV : HIV-1 PR (T80N) with ASN+DIQ+HPH+NTB+PO4+QNC (saquinavir), 1.50A, P 21 21 21 2FNS : HIV-1 PR (D25N) with PEPTIDE+ACT+PO4, 1.85A, P 21 21 21 2FNT : HIV-1 PR (V82A, D25N) with PEPTIDE+ACT+PO4, 1.44A, P 21 21 21 2FXD : HIV-1 PR (IRM mutant) with ACT+DR7+SO4 (atazanavir), 1.60A, P 21 21 21 2FXE : HIV-1 PR (CRM mutant) with ACT+DR7+GOL+SO4 (atazanavir), 1.80A, P 21 21 21 2HS1 : HIV-1 PR (V32I) with 017+CL+DMS (darunavir), 0.84A, P 21 21 21 2HS2 : HIV-1 PR (M46L) with 017+CL+DMS (darunavir), 1.22A, P 21 21 21 2I0A : HIV-1 PR with GOL+MUI+PO4, 1.80A, P 21 21 21 2I0D : HIV-1 PR with ACT+MUT+PO4, 1.95A, P 21 21 21 2IDW : HIV-1 PR (V82A) with 017+ACY+CL+DMS+GOL+PO4, 1.10A, P 21 21 21 2J9J : HIV-1 PR with PEPTIDE+ACT+GOL+SO4, 1.04A, P 21 21 21 2J9K : HIV-1 PR with PEPTIDE+ACE+ACT+GOL+NH2+SO4, 1.20A, P 21 21 21 2JE4 : HIV-1 PR with PEPTIDE+ACT+GOL+SO4, 1.07A, P 21 21 21 2NMW : HIV-1 PR with FMT+SO4+ROC (saquinavir), 1.16A, P 21 21 21 2NMZ : HIV-1 PR (V82A) with SO4+ROC (saquinavir), 0.97A, P 21 21 21 2NNP : HIV-1 PR (I84V) with ACY+GOL+SO4+ROC (saquinavir), 1.20A, P 21 21 21 2NXD : HIV-1 PR (D25N) with peptide, 2.00A, p 21 21 21 2NXL : HIV-1 PR (D25N) with peptide+PO4, 2.00A, P 21 21 21 2NXM : HIV-1 PR (D25N) with peptide, 2.25A, P 21 21 21 2O40 : HIV-1 PR (TETHERED) with PEPTIDE+ACE, 1.65A, P 21 21 21 2PSU : HIV-1 PR with ACT+MUU+PO4, 1.93A, P 21 21 21 2PSV : HIV-1 PR with ACT+MUV+PO4, 1.75A, P 21 21 21 2Q3K : HIV-1 PR with ACT+MUW+PO4, 2.00A, P 21 21 21 2Q54 : HIV-1 PR with ACT+MU1+PO4, 1.85A, P 21 21 21 2Q55 : HIV-1 PR with MU0+PO4, 1.90A, P 21 21 21 2Q5K : HIV-1 PR with PO4+AB1 (lopinavir), 1.95A, P 21 21 21 2QD7 : HIV-1 PR (V82A) with ADMS+GOL+PO4, 1.11A, P 21 21 21 2QHY : HIV-1 PR with ACT+PO4, 1.85A, P 21 21 21 2QHZ : HIV-1 PR with PO4, 1.85A, P 21 21 21 2QI0 : HIV-1 PR with PO4, 2.10A, P 21 21 21 2QI1 : HIV-1 PR with PO4, 2.00A, P 21 21 21 2QI3 : HIV-1 PR with PO4, 1.95A, P 21 21 21 2QI4 : HIV-1 PR with ACT+PO4, 1.80A, P 21 21 21 2QI5 : HIV-1 PR with PO4, 1.85A, P 21 21 21 2QI6 : HIV-1 PR with PO4, 1.85A, P 21 21 21 2QI7 : HIV-1 PR with ACT+PO4, 1.85A, P 21 21 21 3AID : HIV-1 PR with ARQ, 2.50A, P 21 21 21 3BHE : HIV-1 PR with BZN, 1.65A, P 21 21 21 3BXR : HIV-1 PR with DRR+SO4, 1.60A, P 21 21 21 3BXS : HIV-1 PR with DRS+SO4, 1.60A, P 21 21 21 3DCK : HIV-1 PR (D25N chemical analogue) PR with PEPTIDE, 1.80A, P 21 21 21 3DCR : HIV-1 PR (chemical analogue) with PEPTIDE, 1.40A, P 21 21 21 4HVP : HIV-1 PR with PEPTIDE+ACE+NH2, 2.30A, P 21 21 21 7HVP : HIV-1 PR with PEPTIDE+ACE+CH2+OME, 2.40A, P 21 21 21 8HVP : HIV-1 PR with PEPTIDE, 2.50A, P 21 21 21 ---NOT USED (Resolution > 2.5A)--------------------------------------------- None